Kiniksa Pharmaceuticals
developing novel therapies cardiovascular
- B2B
About Kiniksa Pharmaceuticals
discovering, acquiring, developing, and commercializing novel therapies focused on cardiovascular diseases with unmet medical needs
Key facts
- Industry
- Biotechnology Research
- Company size
- 251–1,000 employees
- Headquarters
- Lexington, Massachusetts, United States
- Founded
- 2015
- Revenue
- $678MFY2025, publicly reported
- Website
- kiniksa.com
Kiniksa Pharmaceuticals at a glance
Kiniksa Pharmaceuticals is a B2B company in the Biotechnology Research industry, headquartered in Lexington, Massachusetts, United States.
Kiniksa Pharmaceuticals was founded in 2015.
Kiniksa Pharmaceuticals has 251–1,000 employees.
Kiniksa Pharmaceuticals's revenue is $678M (FY2025, publicly reported).
Frequently asked questions about Kiniksa Pharmaceuticals
What is Kiniksa Pharmaceuticals's revenue?
Kiniksa Pharmaceuticals's revenue is $678M (FY2025, publicly reported).
How many employees does Kiniksa Pharmaceuticals have?
Kiniksa Pharmaceuticals has 251–1,000 employees.
Where is Kiniksa Pharmaceuticals headquartered?
Kiniksa Pharmaceuticals is headquartered in Lexington, Massachusetts, United States.
Selling to companies like Kiniksa Pharmaceuticals?
Tamtam finds the companies that match your ideal customer, researches each account and tells you who to contact and when.
Find similar companies